Tuesday, September 23, 2008
TraumaCure Receives CE Mark Clearance to Sell WoundStat in Europe
TraumaCure Inc. announced today that its ground-breaking hemostatic agent, WoundStat™, has received CE Mark approval, clearing the way for sales in the European Union and all countries recognizing the CE Mark. CE Mark approval from the European Union certifies WoundStat has met health, safety and environmental requirements for consumer safety.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment